Bladder cancer assay
This article was originally published in The Gray Sheet
Executive Summary
Urine testing for activity of the enzyme telomerase is 90% sensitive and 88% specific in detecting bladder cancer in a 218-patient case-control study reported in the Oct. 26 issue of the Journal of the American Medical Association. Maria Sanchini, MSc, Morgani-Pierantoni Hospital, Forli, Italy, et al., suggest the test is a less-invasive, less-costly, and, in some cases, more sensitive alternative to established approaches to bladder cancer diagnosis...
You may also be interested in...
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.